news
Low dose injectable could aid prenatal depression
Research suggests that for every five mothers given low dose esketamine, one major depressive episode could be prevented.
List view / Grid view
Prenatal
news
ObsEva initiates Phase 1 clinical program of OBE022 for the treatment of preterm labor
28 July 2016 | By ObsEva
ObsEva initiates Phase 1 clinical program of OBE022, a first-in-class orally active Prostaglandin F2alpha antagonist, for the treatment of preterm labor...
news
Topline results from Phase II study of SHP607 in extremely premature infants
30 June 2016 | By Victoria White, Digital Content Producer
While the study did not meet its primary endpoint of reducing severity of ROP, it did produce encouraging secondary endpoints related to lung and brain...
news
Innovative blood test can be used as a predictive tool for preeclampsia
7 January 2016 | By Nicholas Jackson
PROGNOSIS study published in the New England Journal of Medicine reveals that an innovative Roche blood test can be used as a predictive tool for preeclampsia...
news
Cuba becomes the first country to eliminate mother-to-child transmission of HIV and syphilis
1 July 2015 | By Victoria White
Cuba has become the first country in the world to receive validation from WHO that it has eliminated mother-to-child transmission of HIV and syphilis...
news
Telbivudine prevents passage of HBV during pregnancy
2 June 2015 | By Victoria White
The antiviral drug telbivudine prevents perinatal transmission of hepatitis B virus (HBV), according to a new study...
news
Rising numbers of preterm births stoke demand for infant care solutions in Europe
23 April 2015 | By Victoria White
The saturated European market for infant care solutions has received fresh impetus from the rising incidence of preterm births, reports Frost & Sullivan...
news
London NHS Trust teams up with Premaitha Health to create the UK’s first centre of excellence for non-invasive prenatal screening (NIPT)
23 March 2015 | By Victoria White
Partnership between the NHS Trust and Premaitha Health means St George's Hospital, London, will be first NHS facility to offer NIPT screening...
news
Roche’s preeclampsia test helps to predict this life-threatening condition in pregnant women at risk
10 December 2014 | By Roche
New data demonstrate high prognostic value of Elecsys blood test...
news
Roche acquires Ariosa Diagnostics and enters the non-invasive prenatal test (NIPT) and cell-free DNA testing services markets
2 December 2014 | By Roche
Roche announced the acquisition of Ariosa Diagnostics, Inc. (Ariosa), a privately-held company based in San Jose, California, USA...
news
ViiV Healthcare announces new grants in support of ending mother to child transmission of HIV
27 November 2014 | By ViiV Healthcare
Landmark number of grants awarded for 2015 as the Positive Action for Children Fund hits 5 year milestone...
